Drug companies agree to work with EU health data regulation

Group representing pharmaceutical industry accepts new rules while highlighting issues still needing clarification

A group representing the European pharmaceutical industry has accepted the final agreement on the European Health Data Space regulation, despite previously expressing “deep concerns” about the progress of the legislation.

The European Federation of Pharmaceutical Industries and Associations published its position on the EHDS agreement on 24 July. The document says Efpia intends to “work constructively” with EU institutions and member states “to address critical aspects that require further clarification within the implementation phase”.